-
1
-
-
69149089036
-
Molecular pathogenesis of Parkinson disease: Insights from genetic studies
-
Gasser, T. (2009) Molecular pathogenesis of Parkinson disease: insights from genetic studies Exp. Rev. Mol. Med. 11, e22
-
(2009)
Exp. Rev. Mol. Med.
, vol.11
, pp. 22
-
-
Gasser, T.1
-
2
-
-
78649389313
-
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
-
Cookson, M. R. (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease Nat. Rev. Neurosci. 11 (12) 791-7
-
(2010)
Nat. Rev. Neurosci.
, vol.11
, Issue.12
, pp. 791-7
-
-
Cookson, M.R.1
-
3
-
-
70350455215
-
LRRK2 in Parkinson's disease: Biochemical functions
-
Anand, V. S. and Braithwaite, S. P. (2009) LRRK2 in Parkinson's disease: biochemical functions FEBS J. 276 (22) 6428-35
-
(2009)
FEBS J.
, vol.276
, Issue.22
, pp. 6428-35
-
-
Anand, V.S.1
Braithwaite, S.P.2
-
4
-
-
72149087091
-
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein
-
Lin, X., Parisiadou, L., Gu, X. L., Wang, L., Shim, H., Sun, L., Xie, C., Long, C. X., Yang, W. J., Ding, J., Chen, Z. Z., Gallant, P. E., Tao-Cheng, J. H., Rudow, G., Troncoso, J. C., Liu, Z., Li, Z., and Cai, H. (2009) Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein Neuron 64 (6) 807-27
-
(2009)
Neuron
, vol.64
, Issue.6
, pp. 807-27
-
-
Lin, X.1
Parisiadou, L.2
Gu, X.L.3
Wang, L.4
Shim, H.5
Sun, L.6
Xie, C.7
Long, C.X.8
Yang, W.J.9
Ding, J.10
Chen, Z.Z.11
Gallant, P.E.12
Tao-Cheng, J.H.13
Rudow, G.14
Troncoso, J.C.15
Liu, Z.16
Li, Z.17
Cai, H.18
-
5
-
-
58149158022
-
Investigation of leucine-rich repeat kinase 2: Enzymological properties and novel assays
-
Anand, V. S., Reichling, L. J., Lipinski, K., Stochaj, W., Duan, W., Kelleher, K., Pungaliya, P., Brown, E. L., Reinhart, P. H., Somberg, R., Hirst, W. D., Riddle, S. M., and Braithwaite, S. P. (2009) Investigation of leucine-rich repeat kinase 2: enzymological properties and novel assays FEBS J. 276 (2) 466-78
-
(2009)
FEBS J.
, vol.276
, Issue.2
, pp. 466-78
-
-
Anand, V.S.1
Reichling, L.J.2
Lipinski, K.3
Stochaj, W.4
Duan, W.5
Kelleher, K.6
Pungaliya, P.7
Brown, E.L.8
Reinhart, P.H.9
Somberg, R.10
Hirst, W.D.11
Riddle, S.M.12
Braithwaite, S.P.13
-
7
-
-
77956441086
-
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
-
Lee, B. D., Shin, J. H., Vankampen, J., Petrucelli, L., West, A. B., Ko, H. S., Lee, Y. I., Maguire-Zeiss, K. A., Bowers, W. J., Federoff, H. J., Dawson, V. L., and Dawson, T. M. (2010) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease Nat. Med. 16, 998-1000
-
(2010)
Nat. Med.
, vol.16
, pp. 998-1000
-
-
Lee, B.D.1
Shin, J.H.2
Vankampen, J.3
Petrucelli, L.4
West, A.B.5
Ko, H.S.6
Lee, Y.I.7
Maguire-Zeiss, K.A.8
Bowers, W.J.9
Federoff, H.J.10
Dawson, V.L.11
Dawson, T.M.12
-
8
-
-
77749255337
-
Kinetic mechanistic studies of wild-type leucine-rich repeat kinase 2: Characterization of the kinase and GTPase activities
-
Liu, M., Dobson, B., Glicksman, M. A., Yue, Z., and Stein, R. L. (2010) Kinetic mechanistic studies of wild-type leucine-rich repeat kinase 2: characterization of the kinase and GTPase activities Biochemistry 49 (9) 2008-17
-
(2010)
Biochemistry
, vol.49
, Issue.9
, pp. 2008-17
-
-
Liu, M.1
Dobson, B.2
Glicksman, M.A.3
Yue, Z.4
Stein, R.L.5
-
9
-
-
42549132243
-
Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074
-
DOI 10.1111/j.1471-4159.2008.05226.x
-
Chen, H. M., Wang, L., and D'Mello, S. R. (2008) Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074 J. Neurochem. 105 (4) 1300-12 (Pubitemid 351590789)
-
(2008)
Journal of Neurochemistry
, vol.105
, Issue.4
, pp. 1300-1312
-
-
Chen, H.-M.1
Wang, L.2
D'Mello, S.R.3
-
10
-
-
69249158109
-
Novel inhibitors complexed with glutamate dehydrogenase: Allosteric regulation by control of protein dynamics
-
Li, M., Smith, C. J., Walker, M. T., and Smith, T. J. (2009) Novel inhibitors complexed with glutamate dehydrogenase: allosteric regulation by control of protein dynamics J. Biol. Chem. 284 (34) 22988-3000
-
(2009)
J. Biol. Chem.
, vol.284
, Issue.34
, pp. 22988-3000
-
-
Li, M.1
Smith, C.J.2
Walker, M.T.3
Smith, T.J.4
-
11
-
-
54449087537
-
Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity
-
Arita, M., Wakita, T., and Shimizu, H. (2008) Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity J. Gen. Virol. 89 (Pt 10) 2518-30
-
(2008)
J. Gen. Virol.
, vol.89
, Issue.PART 10
, pp. 2518-30
-
-
Arita, M.1
Wakita, T.2
Shimizu, H.3
-
12
-
-
79952918505
-
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
-
Deng, X., Dzamko, N., Prescott, A., Davies, P., Liu, Q., Yang, Q., Lee, J. D., Patricelli, M. P., Nomanbhoy, T. K., Alessi, D. R., and Gray, N. S. (2011) Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2 Nat. Chem. Biol. 7 (4) 203-5
-
(2011)
Nat. Chem. Biol.
, vol.7
, Issue.4
, pp. 203-5
-
-
Deng, X.1
Dzamko, N.2
Prescott, A.3
Davies, P.4
Liu, Q.5
Yang, Q.6
Lee, J.D.7
Patricelli, M.P.8
Nomanbhoy, T.K.9
Alessi, D.R.10
Gray, N.S.11
-
13
-
-
34948875686
-
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
-
DOI 10.1038/nbt1328, PII NBT1328
-
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., Reader, V., Sweetman, G., Bauer, A., Bouwmeester, T., Hopf, C., Kruse, U., Neubauer, G., Ramsden, N., Rick, J., Kuster, B., and Drewes, G. (2007) Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors Nat. Biotechnol. 25 (9) 1035-44 (Pubitemid 47517638)
-
(2007)
Nature Biotechnology
, vol.25
, Issue.9
, pp. 1035-1044
-
-
Bantscheff, M.1
Eberhard, D.2
Abraham, Y.3
Bastuck, S.4
Boesche, M.5
Hobson, S.6
Mathieson, T.7
Perrin, J.8
Raida, M.9
Rau, C.10
Reader, V.11
Sweetman, G.12
Bauer, A.13
Bouwmeester, T.14
Hopf, C.15
Kruse, U.16
Neubauer, G.17
Ramsden, N.18
Rick, J.19
Kuster, B.20
Drewes, G.21
more..
-
14
-
-
79952396960
-
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
-
Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A. M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., Boesche, M., Delling, M., Dumpelfeld, B., Eberhard, D., Huthmacher, C., Mathieson, T., Poeckel, D., Reader, V., Strunk, K., Sweetman, G., Kruse, U., Neubauer, G., Ramsden, N. G., and Drewes, G. (2011) Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes Nat. Biotechnol. 29 (3) 255-65
-
(2011)
Nat. Biotechnol.
, vol.29
, Issue.3
, pp. 255-65
-
-
Bantscheff, M.1
Hopf, C.2
Savitski, M.M.3
Dittmann, A.4
Grandi, P.5
Michon, A.M.6
Schlegl, J.7
Abraham, Y.8
Becher, I.9
Bergamini, G.10
Boesche, M.11
Delling, M.12
Dumpelfeld, B.13
Eberhard, D.14
Huthmacher, C.15
Mathieson, T.16
Poeckel, D.17
Reader, V.18
Strunk, K.19
Sweetman, G.20
Kruse, U.21
Neubauer, G.22
Ramsden, N.G.23
Drewes, G.24
more..
-
15
-
-
78651340521
-
Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells
-
Kruse, U., Pallasch, C. P., Bantscheff, M., Eberhard, D., Frenzel, L., Ghidelli, S., Maier, S. K., Werner, T., Wendtner, C. M., and Drewes, G. (2010) Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells Leukemia 25 (1) 89-100
-
(2010)
Leukemia
, vol.25
, Issue.1
, pp. 89-100
-
-
Kruse, U.1
Pallasch, C.P.2
Bantscheff, M.3
Eberhard, D.4
Frenzel, L.5
Ghidelli, S.6
Maier, S.K.7
Werner, T.8
Wendtner, C.M.9
Drewes, G.10
-
16
-
-
77956836941
-
Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays
-
Savitski, M. M., Fischer, F., Mathieson, T., Sweetman, G., Lang, M., and Bantscheff, M. (2010) Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays J. Am. Soc. Mass Spectrom. 21, 1668-79
-
(2010)
J. Am. Soc. Mass Spectrom.
, vol.21
, pp. 1668-79
-
-
Savitski, M.M.1
Fischer, F.2
Mathieson, T.3
Sweetman, G.4
Lang, M.5
Bantscheff, M.6
-
17
-
-
76349085159
-
Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen
-
Maekawa, T., Kubo, M., Yokoyama, I., Ohta, E., and Obata, F. (2010) Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen Biochem. Biophys. Res. Commun. 392 (3) 431-5
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.392
, Issue.3
, pp. 431-5
-
-
Maekawa, T.1
Kubo, M.2
Yokoyama, I.3
Ohta, E.4
Obata, F.5
-
18
-
-
68249100438
-
Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors
-
Olaharski, A. J., Gonzaludo, N., Bitter, H., Goldstein, D., Kirchner, S., Uppal, H., and Kolaja, K. (2009) Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors PLoS Comput. Biol. 5 (7) e1000446
-
(2009)
PLoS Comput. Biol.
, vol.5
, Issue.7
, pp. 1000446
-
-
Olaharski, A.J.1
Gonzaludo, N.2
Bitter, H.3
Goldstein, D.4
Kirchner, S.5
Uppal, H.6
Kolaja, K.7
-
19
-
-
77958491690
-
Modeling bone marrow toxicity using kinase structural motifs and the inhibition profiles of small molecular kinase inhibitors
-
Olaharski, A. J., Bitter, H., Gonzaludo, N., Kondru, R., Goldstein, D. M., Zabka, T. S., Lin, H., Singer, T., and Kolaja, K. (2010) Modeling bone marrow toxicity using kinase structural motifs and the inhibition profiles of small molecular kinase inhibitors Toxicol. Sci. 118 (1) 266-75
-
(2010)
Toxicol. Sci.
, vol.118
, Issue.1
, pp. 266-75
-
-
Olaharski, A.J.1
Bitter, H.2
Gonzaludo, N.3
Kondru, R.4
Goldstein, D.M.5
Zabka, T.S.6
Lin, H.7
Singer, T.8
Kolaja, K.9
-
20
-
-
33748993710
-
Kinase activity of mutant LRRK2 mediates neuronal toxicity
-
DOI 10.1038/nn1776, PII NN1776
-
Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M., and Ross, C. A. (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity Nat. Neurosci. 9 (10) 1231-3 (Pubitemid 44454261)
-
(2006)
Nature Neuroscience
, vol.9
, Issue.10
, pp. 1231-1233
-
-
Smith, W.W.1
Pei, Z.2
Jiang, H.3
Dawson, V.L.4
Dawson, T.M.5
Ross, C.A.6
-
21
-
-
29444437871
-
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
-
DOI 10.1073/pnas.0508052102
-
Smith, W. W., Pei, Z., Jiang, H., Moore, D. J., Liang, Y., West, A. B., Dawson, V. L., Dawson, T. M., and Ross, C. A. (2005) Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration Proc. Natl. Acad. Sci. U.S.A. 102 (51) 18676-81 (Pubitemid 43011285)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.51
, pp. 18676-18681
-
-
Smith, W.W.1
Pei, Z.2
Jiang, H.3
Moore, D.J.4
Liang, Y.5
West, A.B.6
Dawson, V.L.7
Dawson, T.M.8
Ross, C.A.9
-
22
-
-
33751256567
-
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology
-
DOI 10.1016/j.neuron.2006.10.008, PII S0896627306008075
-
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., and Abeliovich, A. (2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology Neuron 52 (4) 587-93 (Pubitemid 44781171)
-
(2006)
Neuron
, vol.52
, Issue.4
, pp. 587-593
-
-
MacLeod, D.1
Dowman, J.2
Hammond, R.3
Leete, T.4
Inoue, K.5
Abeliovich, A.6
-
23
-
-
0033179479
-
Paradoxical activation of Raf by a novel Raf inhibitor
-
DOI 10.1016/S1074-5521(99)80088-X
-
Hall-Jackson, C. A., Eyers, P. A., Cohen, P., Goedert, M., Boyle, F. T., Hewitt, N., Plant, H., and Hedge, P. (1999) Paradoxical activation of Raf by a novel Raf inhibitor Chem. Bio.l 6 (8) 559-68 (Pubitemid 29380770)
-
(1999)
Chemistry and Biology
, vol.6
, Issue.8
, pp. 559-568
-
-
Hall-Jackson, C.A.1
Eyers, P.A.2
Cohen, P.3
Goedert, M.4
Boyle, F.T.5
Hewitt, N.6
Plant, H.7
Hedge, P.8
-
24
-
-
21344443715
-
ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells
-
DOI 10.1158/1535-7163.MCT-04-0334
-
Van Gompel, J. J., Kunnimalaiyaan, M., Holen, K., and Chen, H. (2005) ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells Mol. Cancer Ther. 4 (6) 910-7 (Pubitemid 40909073)
-
(2005)
Molecular Cancer Therapeutics
, vol.4
, Issue.6
, pp. 910-917
-
-
Van Gompel, J.J.1
Kunnimalaiyaan, M.2
Holen, K.3
Chen, H.4
-
25
-
-
40949145205
-
Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease
-
Westerlund, M., Belin, A. C., Anvret, A., Bickford, P., Olson, L., and Galter, D. (2008) Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease Neuroscience 152 (2) 429-36
-
(2008)
Neuroscience
, vol.152
, Issue.2
, pp. 429-36
-
-
Westerlund, M.1
Belin, A.C.2
Anvret, A.3
Bickford, P.4
Olson, L.5
Galter, D.6
-
26
-
-
69549148386
-
The genetics of Crohn's disease
-
Van Limbergen, J., Wilson, D. C., and Satsangi, J. (2009) The genetics of Crohn's disease Annu. Rev. Genomics Hum. Genet. 10, 89-116
-
(2009)
Annu. Rev. Genomics Hum. Genet.
, vol.10
, pp. 89-116
-
-
Van Limbergen, J.1
Wilson, D.C.2
Satsangi, J.3
-
27
-
-
78149473340
-
LRRK2 is involved in the IFN-gamma response and host response to pathogens
-
Gardet, A., Benita, Y., Li, C., Sands, B. E., Ballester, I., Stevens, C., Korzenik, J. R., Rioux, J. D., Daly, M. J., Xavier, R. J., and Podolsky, D. K. (2010) LRRK2 is involved in the IFN-gamma response and host response to pathogens J. Immunol. 185 (9) 5577-85
-
(2010)
J. Immunol.
, vol.185
, Issue.9
, pp. 5577-85
-
-
Gardet, A.1
Benita, Y.2
Li, C.3
Sands, B.E.4
Ballester, I.5
Stevens, C.6
Korzenik, J.R.7
Rioux, J.D.8
Daly, M.J.9
Xavier, R.J.10
Podolsky, D.K.11
-
28
-
-
61849105469
-
Mass spectrometry based targeted protein quantification: Methods and applications
-
Pan, S., Aebersold, R., Chen, R., Rush, J., Goodlett, D. R., McIntosh, M. W., Zhang, J., and Brentnall, T. A. (2009) Mass spectrometry based targeted protein quantification: methods and applications J. Proteome Res. 8 (2) 787-97
-
(2009)
J. Proteome Res.
, vol.8
, Issue.2
, pp. 787-97
-
-
Pan, S.1
Aebersold, R.2
Chen, R.3
Rush, J.4
Goodlett, D.R.5
McIntosh, M.W.6
Zhang, J.7
Brentnall, T.A.8
-
29
-
-
70349624519
-
Proteomics strategy for quantitative protein interaction profiling in cell extracts
-
Sharma, K., Weber, C., Bairlein, M., Greff, Z., Keri, G., Cox, J., Olsen, J. V., and Daub, H. (2009) Proteomics strategy for quantitative protein interaction profiling in cell extracts Nat. Methods 6 (10) 741-4
-
(2009)
Nat. Methods
, vol.6
, Issue.10
, pp. 741-4
-
-
Sharma, K.1
Weber, C.2
Bairlein, M.3
Greff, Z.4
Keri, G.5
Cox, J.6
Olsen, J.V.7
Daub, H.8
-
30
-
-
28044460070
-
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
-
DOI 10.1073/pnas.0507360102
-
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., and Dawson, T. M. (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity Proc. Natl. Acad. Sci. U.S.A. 102 (46) 16842-7 (Pubitemid 41688864)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.46
, pp. 16842-16847
-
-
West, A.B.1
Moore, D.J.2
Biskup, S.3
Bugayenko, A.4
Smith, W.W.5
Ross, C.A.6
Dawson, V.L.7
Dawson, T.M.8
|